Truvestments Capital’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed -$9 1094
2025
Q3
$9 Sell
1
-68
-99% -$523 ﹤0.01% 1044
2025
Q2
$418 Buy
69
+1
+1% +$8 ﹤0.01% 903
2025
Q1
$842 Hold
68
﹤0.01% 938
2024
Q4
$942 Hold
68
﹤0.01% 924
2024
Q3
$1.14K Buy
+68
New +$1.46K ﹤0.01% 847
2024
Q2
Sell
-108
Closed -$2.67K 559
2024
Q1
$2.67K Hold
108
﹤0.01% 595
2023
Q4
$3.92K Hold
108
﹤0.01% 622
2023
Q3
$5.21K Hold
108
﹤0.01% 509
2023
Q2
$7.37K Hold
108
﹤0.01% 485
2023
Q1
$5.24K Buy
+108
New +$5.71K ﹤0.01% 507

Other funds holding PRTA

Truvestments Capital's PRTA Position: Q4 2025 in Review

Truvestments Capital sold out of Prothena Corp (PRTA) in Q4 2025, closing a stake of 1 share — an estimated $9 sold.

Truvestments Capital first reported a position in PRTA in Q1 2023 and held it in 10 quarters. The position peaked at $7.37K in Q2 2023. 181 funds tracked by Wall St. Rank hold PRTA as of Q4 2025.

  • Truvestments Capital reported no remaining Prothena Corp position as of Q4 2025 after selling out during the quarter.
  • Truvestments Capital sold 1 Prothena Corp share in Q4 2025, an estimated $9.
  • Truvestments Capital first reported a position in Prothena Corp in Q1 2023 and held it in 10 quarters.
  • Truvestments Capital's Prothena Corp position peaked at $7.37K in Q2 2023.
  • 181 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2025.

Based on Truvestments Capital's 13F filing for Q4 2025, filed 13 Feb 2026.